In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019

In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019

The Antimicrobial Testing Leadership and Surveillance (ATLAS) global surveillance program collected clinical isolates of Enterobacterales (n = 8416) and Pseudomonas aeruginosa (n = 2521) from 41 medical centers in 10 Latin American countries from 2017 to 2019. In vitro activities of ceftazidime-avib...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: James A. Karlowsky, Krystyna M. Kazmierczak, Maria Lavínea Novis de Figueiredo Valente, Elkin Lemos Luengas, Monique Baudrit, Alvaro Quintana, Paurus Irani, Gregory G. Stone, Daniel F. Sahm
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Ceftazidime-avibactam
Latin America
Surveillance
Gram-negative
Enterobacterales
Pseudomonas aeruginosa
Infectious and parasitic diseases
RC109-216
Microbiology
QR1-502
Accès en ligne:https://doaj.org/article/0a60f6b6ac304f39b06d01229151dcd9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/0a60f6b6ac304f39b06d01229151dcd9

Documents similaires